A computational method developed in the UCSF School of Pharmacy under the direction of faculty member Brian Shoichet, PhD, has the potential to predict new target diseases for existing drugs as well as unexpected side effects of approved drugs.
While the development of a specific drug to affect a specific disease...
The University of California, San Francisco-operated California Poison Control System (CPCS), which had already sent layoff notices to its employees January 15, 2010, has secured funding to rescind the notices and continue to care for Californians, through June 2010, via its free and immediate 24 hour per day, 7 days per week advice and...
The Scientist has cited a UCSF innovation among its top 10 list of tools to hit the life sciences in 2009. In the spotlight is a paper that reveals how to import plant "light switches" into mammalian cells to control complex regulatory processes. The paper appeared in the October 15, 2009 issue of Nature. Authors are the UCSF...
Helene Levens Lipton, PhD, faculty member in the UCSF School of Pharmacy, presents data in support of including pharmacists in the medical home model of health care. Her editorial appears in the November 23, 2009 issue of the Archives of Internal Medicine.
Press Release: Team-Based Care and Medical Homes May...
Takeda San Francisco, Inc., announced September 21, 2009 that it has entered into a sponsored collaboration with UCSF to support antibody-related research in the laboratory of Charles S. Craik, PhD, faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy. Craik will be the...
UCSF researcher Deanna Kroetz, PhD, discusses the impact of genetic differences on how an individual responds to drugs in a KQED Quest radio interview that aired September 14, 2009. Fellow members of the interview panel were UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, and UCSF breast cancer surgeon...
Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of HER2, trastuzumab can be highly effective. These...
Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.
According to the National Cancer Institute (NCI), "To advance the NCI's mission of bringing novel therapies to patients, and to fully exploit...
UCSF School of Pharmacy researchers and colleagues have successfully created a mathematical model that genetically programs bacteria and causes the bacteria to "trace" images projected onto them in a petri dish. The bacteria sense and display the area of the projection where light meets dark by producing a visible black pigment. The result is...